Evidence map›Paper›PMID 27930353›Full record

ArticleJournal of the American Heart Association2016

Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus.

Murat Sezer, Mehmet Kocaaga, Emre Aslanger, Adem Atici, Ahmet Demirkiran, Zehra Bugra, Sabahattin Umman, Berrin Umman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Effect of Glucose Metabolic State Transition on Progression from Stage A to Stage C Heart Failure.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Coronary microvascular dysfunction in heart failure patients.Frontiers in cardiovascular medicine · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Murat SezerDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey sezerm@istanbul.edu.tr sezermr@gmail.com.
Mehmet KocaagaDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Emre AslangerDepartment of Cardiology, School of Medicine, Yeditepe University, Istanbul, Turkey.
Adem AticiDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Ahmet DemirkiranDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Zehra BugraDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sabahattin UmmanDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Berrin UmmanDepartment of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Istanbul University · TRYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe contribution of functionally disturbed coronary autoregulation and structurally impaired microvascular vasodilatory function to reduced coronary flow velocity reserve, reflecting impaired coronary microcirculation in diabetes mellitus (DM), has not been clearly elucidated. The objective of this study was to identify the mechanism of coronary microvascular impairment in DM in relation to duration of disease. METHODS AND

resultsCoronary flow velocities in the anterior descending coronary artery were assessed by transthoracic echocardiography following angiography revealing normal epicardial coronary arteries in 55 diabetic and 47 nondiabetic patients. Average peak flow velocities, coronary flow velocity reserve, and microvascular resistance in baseline and hyperemic conditions (baseline and hyperemic microvascular resistance, respectively) were assessed. Reduced coronary flow velocity reserve in patients with short duration (<10 years) of DM compared with nondiabetic patients was primarily driven by increased baseline average peak flow velocity (26.50±5.6 versus 22.08±4.31, P=0.008) in the presence of decreased baseline microvascular resistance (3.69±0.86 versus 4.34±0.76, P=0.003). In contrast, decreased coronary flow velocity reserve in patients with long-standing (≥10 years) DM compared with nondiabetic patients was predominantly driven by reduced hyperemic average peak flow velocity (41.57±10.01 versus 53.47±11.8, P<0.001) due to increased hyperemic microvascular resistance (2.13±0.42 versus 1.69±0.39, P<0.001).

conclusionsBoth altered coronary autoregulation and impaired microvascular vasodilatory function contribute to DM-related coronary microvascular impairment in a time-dependent manner. DM-induced early functional microvascular autoregulatory impairment seems to evolve into structural microvascular impairment in the initially overperfused microvascular territory at the later stage of disease.

Indexed as

AgedCase-Control StudiesCoronary AngiographyCoronary CirculationCoronary VesselsDiabetes Mellitus, Type 2Diabetic AngiopathiesEchocardiography, DopplerFemaleHumansMaleMicrocirculationMicrovesselsMiddle AgedRegional Blood FlowTime Factorscoronary arteriolescoronary microcirculationcoronary microvascular functioncoronary microvascular resistancediabetes mellitus

Identifiers

PMID27930353
PMCPMC5210326
OpenAlexW2549913707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.